Br[C:2]1[CH:3]=[C:4]([O:9][C@@H:10]([C:12]2[CH:17]=[C:16]([F:18])[CH:15]=[CH:14][C:13]=2[N:19]2[N:23]=[CH:22][CH:21]=[N:20]2)[CH3:11])[C:5]([NH2:8])=[N:6][CH:7]=1.[F:24][C:25]1[C:30]([F:31])=[C:29](B(O)O)[CH:28]=[CH:27][N:26]=1.[F-].[Cs+]>CO.O>[F:24][C:25]1[C:30]([F:31])=[C:29]([C:2]2[CH:7]=[N:6][C:5]([NH2:8])=[C:4]([O:9][C@@H:10]([C:12]3[CH:17]=[C:16]([F:18])[CH:15]=[CH:14][C:13]=3[N:19]3[N:23]=[CH:22][CH:21]=[N:20]3)[CH3:11])[CH:3]=2)[CH:28]=[CH:27][N:26]=15-Bromo-3-[(R)-1-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-ethoxy]-pyridin-2-ylamine (example 45) (200 mg, 0.529 mmol, 1.0 eq) and 2,3-difluoropyridin-4-ylboronic acid (168 mg, 1.06 mmol, 2.0 eq) were dissolved in MeOH (5 mL), followed by the addition of freshly prepared aqueous solution of CsF (563 mg, 3.5 mmol, 7 eq) in water (3.34 mL) and Pd-132 (64 mg, 0.09 mmol, 0.17 eq), then degassed for three times. The mixture was heated up to 80° C. for overnight. LCMS showed >80% conversion to desired product, and ˜10% of des-bromation of example 45. The reaction mixture was filtered. The filtrate was concentrated and purified via a Biotage silica gel cartridge to provide the title compound (174 mg) as a white solid.
Loading…